Watson harnessed to link cancer patients with potential clinical trials

Researchers from Melbourne's Peter MacCallum Cancer Centre have been trialling IBM's Watson artificial intelligence technology to see if they can better match cancer patients to relevant clinical trials.

In a recent retrospective study, the Peter Mac researchers used past records of 102 lung cancer patients and matched each patient to 10 potential trials using IBM Watson for Clinical Trial Matching, which helps optimise trial recruitment at the point of care.

Posted in Australian eHealth

Tags: IBM, Peter Mac, Watson

Add comment

Please note comments of a self-promotional nature are likely to be deleted.

Security code

Sign up for Pulse+IT eNewsletters

Sign up for Pulse+IT website access

For more information, click here.

Copyright © 2020 Pulse+IT Magazine
No content published on this website can be reproduced by any person for any reason without the prior written permission of the publisher.